MDT - Medtronic Plc

NYSE * Health Care * Health Care Equipment & Supplies

$97.66

+$0.63 (+0.65%)

About Medtronic Plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

MDT Key Statistics

Market Cap

$125.38B

P/E Ratio

27.28

P/B Ratio

2.56

EPS

$3.58

Dividend Yield

0.03%

Revenue Growth

+0.1%

Profit Margin

0.1%

Employees

95,000

How MDT Compares to Peers

MDT has the lowest P/E ratio in Health Care Equipment & Supplies, suggesting it may be the most undervalued
MDT has the highest profit margins in Health Care Equipment & Supplies
MDT is the smallest among peers, which may offer higher growth potential

P/E Rank

#1

of 2

Margin Rank

#1

of 2

Growth Rank

#2

of 2

Size Rank

#2

of 2

CompanyP/EGrowthCompare
MDT27.30%-
AMZN29.00%vs AMZN

Medtronic Plc Company Information

Headquarters
Ireland
Website
www.medtronic.com
Sector
Health Care
Industry
Health Care Equipment & Supplies
Data Updated:
Ready to invest in MDT?

Commission-free trading available. Affiliate links.

MDT Lician Score

10% confidence
6.0/10
Good

MDT has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

8.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates MDTacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

MDT Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

35810Value5.0Growth8.0Quality5.0Momentum5.0Safety5.05.6/10
5.0

Value

8.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for MDT